Lysophosphatidic acid induces shear stress-dependent contraction in mouse aortic strip in situ

Journal of Cardiovascular Pharmacology

Volumn 62, Issue 6, 2013, Pages 530-538

  Niioka, Takeharu ^a   Ohata, Hisayuki ^b   Momose, Kazutaka ^b   Honda, Kazuo ^b  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Lysophosphatidic acid; Mechanotransduction; Mouse aorta; Shear stress; Vasoconstriction

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLSALICYLIC ACID; CALCIUM ION; LYSOPHOSPHATIDIC ACID; OZAGREL; PHENYLEPHRINE; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA STRIP; ARTICLE; CELL MOTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW RATE; LASER MICROSCOPY; MALE; MECHANOTRANSDUCTION; MOUSE; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; REAL TIME TWO PHOTON LASER SCANNING MICROSCOPY; SHEAR STRESS; SMOOTH MUSCLE FIBER; VASOCONSTRICTION;

ANIMALS; AORTA, THORACIC; CALCIUM SIGNALING; CELL MOVEMENT; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; LYSOPHOSPHOLIPIDS; MALE; MECHANOTRANSDUCTION, CELLULAR; MICE; MICE, INBRED STRAINS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SHEAR STRENGTH; STRESS, PHYSIOLOGICAL; THROMBOXANE A2; THROMBOXANE-A SYNTHASE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84890547264     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000013     Document Type: Article

References (41)

1. Davies PF, Mundel T, Barbee KA. A mechanism for heterogeneous endothelial responses to flow in vivo and in vitro. J Biomech. 1995;28: 1553-1560.
2. Hahn C, Schwartz MA. Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol. 2009;10: 53-62.
3. Topper JN, Gimbrone MA Jr. Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol Med Today. 1999;5: 40-46.
4. Yamamoto K, Ando J. Mechanosensing of blood flow in vascular endothelial cells. Nippon Yakurigaku Zasshi. 2011;138: 196-200.
5. Liu B, Lu S, Zheng S, et al. Two distinct phases of calcium signalling under flow. Cardiovasc Res. 2011;91: 124-133.
6. AbouAlaiwi WA, Takahashi M, Mell BR, et al. Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades. Circ Res. 2009;104: 860-869.
7. Woo K, Dutta AK, Patel V, et al. Fluid flow induces mechanosensitive ATP release, calcium signalling and Cl- transport in biliary epithelial cells through a PKCzeta-dependent pathway. J Physiol. 2008;586 (pt 11): 2779-2798.
8. Nauli SM, Kawanabe Y, Kaminski JJ, et al. Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation. 2008;117: 1161-1171.
9. Ohata H, Tanaka K, Maeyama N, et al. Visualization of elementary mechanosensitive Ca2+-influx events, Ca2+ spots, in bovine lens epithelial cells. J Physiol. 2001;532: 31-42.
10. Ohata H, Yamada H, Momose K. Lysophosphatidic acid induces shear stress-dependent Ca2+ influx in mouse aortic endothelial cells in situ. Exp Physiol. 2011;96: 468-475.
11. Shibata K, Miyazaki T, Ohata H, et al. Shear stress-dependent effects of lysophosphatidic acid on agonist-induced vasomotor responses in rat mesenteric artery. J Cardiovasc Pharmacol. 2011;57: 604-610.
12. Ohata H, Yamada H, Niioka T, et al. Optical bioimaging: from living tissue to a single molecule: calcium imaging in blood vessel in situ employing two-photon excitation fluorescence microscopy. J Pharmacol Sci. 2003;93: 242-247.
13. Ohata H, Niioka T, Kim MS, et al. Role of lysophosphatidic acid as a mechanosensitizer. Nippon Yakurigaku Zasshi. 2004;124: 329-335.
14. Ohata H, Ikeuchi T, Kamada A, et al. Lysophosphatidic acid positively regulates the fluid flow-induced local Ca2+ influx in bovine aortic endothelial cells. Circ Res. 2001;88: 925-932.
15. Siess W, Zangl KJ, Essler M, et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A. 1999;96: 6931-6936.
16. Baker DL, Desiderio DM, Miller DD, et al. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry. Anal Biochem. 2001;292: 287-295.
17. Schober A, Siess W. Lysophosphatidic acid in atherosclerotic diseases. Br J Pharmacol. 2012;167: 465-482.
18. Williams JR, Khandoga AL, Goyal P, et al. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem. 2009;284: 17304-17319.
19. Khandoga AL, Fujiwara Y, Goyal P, et al. Lysophosphatidic acidinduced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin. Platelets. 2008;19: 415-427.
20. Lin CI, Chen CN, Lin PW, et al. Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3. Biochem Biophys Res Commun. 2007;363: 1001-1008.
21. Rizza C, Leitinger N, Yue J, et al. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction. Lab Invest. 1999;79: 1227-1235.
22. Chang CL, Hsu HY, Lin HY, et al. Lysophosphatidic acid-induced oxidized low-density lipoprotein uptake is class A scavenger receptor-dependent in macrophages. Prostaglandins Other Lipid Mediat. 2008;87: 20-25.
23. Komachi M, Damirin A, Malchinkhuu E, et al. Signaling pathways involved in DNA synthesis and migration in response to lysophosphatidic acid and low-density lipoprotein in coronary artery smooth muscle cells. Vascul Pharmacol. 2009;50: 178-184.
24. Tokumura A, Iimori M, Nishioka Y, et al. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol. 1994;267(1 pt 1):C204-C210.
25. Hayashi K, Takahashi M, Nishida W, et al. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res. 2001;89: 251-258.
26. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999;282: 2035-2042.
27. Zarins CK, Giddens DP, Bharadvaj BK, et al. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res. 1983;53: 502-514.
28. Asakura T, Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ Res. 1990;66: 1045-1066.
29. Gibson CM, Diaz L, Kandarpa K, et al. Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb. 1993;13: 310-315.
30. Nadaud S, Philippe M, Arnal JF, et al. Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ Res. 1996;79: 857-863.
31. Chen C, Ochoa LN, Kagan A, et al. Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Atherosclerosis. 2012;222: 74-83.
32. Asano H, Shimizu K, Muramatsu M, et al. Prostaglandin H2 as an endothelium-derived contracting factor modulates endothelin-1-induced contraction. J Hypertens. 1994;12: 383-390.
33. Dai FX, Skopec J, Diederich A, et al. Prostaglandin H2 and thromboxane A2 are contractile factors in intrarenal arteries of spontaneously hypertensive rats. Hypertension. 1992;19(6 pt 2): 795-798.
34. Huang A, Sun D, Koller A. Shear stress-induced release of prostaglandin H2 in arterioles of hypertensive rats. Hypertension. 2000;35: 925-930.
35. Lin L, Balazy M, Pagano PJ, et al. Expression of prostaglandin H2-mediated mechanism of vascular contraction in hypertensive rats. Relation to lipoxygenase and prostacyclin synthase activities. Circ Res. 1994;74: 197-205.
36. Maruyama J, Yokochi A, Maruyama K, et al. Acetylcholine-induced endothelium-derived contracting factor in hypoxic pulmonary hypertensive rats. J Appl Physiol. 1999;86: 1687-1695.
37. Shimizu K, Muramatsu M, Kakegawa Y, et al. Role of prostaglandin H2 as an endothelium-derived contracting factor in diabetic state. Diabetes. 1993;42: 1246-1252.
38. Soler M, Camacho M, Escudero JR, et al. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ Res. 2000;87: 504-507.
39. Saito M, Tanabe Y, Kudo I, et al. Endothelium-derived prostaglandin H2 evokes the stretch-induced contraction of rabbit pulmonary artery. Eur J Pharmacol. 2003;467: 151-161.
40. Tanabe Y, Saito M, Morikawa Y, et al. Inhibition of untransformed prostaglandin H2 production and stretch-induced contraction of rabbit pulmonary arteries by indoxam, a selective secretory phospholipase A2 inhibitor. J Pharmacol Sci. 2011;115: 525-531.
41. Tokumura A, Yotsumoto T, Masuda Y, et al. Vasopressor effect of lysophosphatidic acid on spontaneously hypertensive rats and Wistar Kyoto rats. Res Commun Mol Pathol Pharmacol. 1995;90: 96-102.